Patents by Inventor Christopher B. Wood

Christopher B. Wood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240147243
    Abstract: An embodiment includes a method to increase the efficiency of security checkpoint operations. A security checkpoint kiosk serves as a Relying Party System (RPS). The RPS establishes a secure local connection between the RPS and a User Mobile-Identification-Credential Device (UMD). The RPS sends a user information request to the UMD, via the secure local connection, seeking release of user information associated with a Mobile Identification Credential (MIC). The RPS obtains authentication of the user information received in response to the user information request. The RPS retrieves user travel information based on the user information. The RPS determines that the user travel information matches the user information. When the user travel information matches the user information, the RPS approves the user to proceed past the security checkpoint kiosk.
    Type: Application
    Filed: January 4, 2024
    Publication date: May 2, 2024
    Inventors: Haya Iris VILLANUEVA GAVIOLA, Gianpaolo FASOLI, Vinay GANESH, Irene M. GRAFF, Martijn Theo HARING, Ahmer A. KHAN, Franck Farian RAKOTOMALALA, Gordon Y. SCOTT, Ho Cheung CHUNG, Antonio ALLEN, Mayura Dhananjaya DESHPANDE, Thomas John MILLER, Christopher SHARP, David W. SILVER, Policarpo B. WOOD, Ka YANG
  • Patent number: 11950101
    Abstract: An embodiment includes a method to increase the efficiency of security checkpoint operations. A security checkpoint kiosk serves as a Relying Party System (RPS). The RPS establishes a secure local connection between the RPS and a User Mobile-Identification-Credential Device (UMD). The RPS sends a user information request to the UMD, via the secure local connection, seeking release of user information associated with a Mobile Identification Credential (MIC). The RPS obtains authentication of the user information received in response to the user information request. The RPS retrieves user travel information based on the user information. The RPS determines that the user travel information matches the user information. When the user travel information matches the user information, the RPS approves the user to proceed past the security checkpoint kiosk.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: April 2, 2024
    Assignee: Apple Inc.
    Inventors: Haya Iris Villanueva Gaviola, Gianpaolo Fasoli, Vinay Ganesh, Irene M. Graff, Martijn Theo Haring, Ahmer A. Khan, Franck Farian Rakotomalala, Gordon Y. Scott, Ho Cheung Chung, Antonio Allen, Mayura Dhananjaya Deshpande, Thomas John Miller, Christopher Sharp, David W. Silver, Policarpo B. Wood, Ka Yang
  • Publication number: 20240107118
    Abstract: Some embodiments described in this disclosure are directed to one or more electronic devices that facilitate control of playback of a live content item displayed in a playback user interface. Some embodiments described in this disclosure are directed to one or more electronic devices that facilitate display of key content corresponding to a live content item in a key content user interface. Some embodiments described in this disclosure are directed to one or more electronic devices that facilitate concurrently display of multiple content items in a Multiview user interface. Some embodiments described in this disclosure are directed to one or more electronic devices that facilitate display of insights corresponding to a content item displayed in a playback user interface.
    Type: Application
    Filed: September 23, 2023
    Publication date: March 28, 2024
    Inventors: Christopher J. ELLINGFORD, Kevin M. SANDLOW, Lucio MORENO RUFO, Fredric R. VINNA, Policarpo B. WOOD, Antonio ALLEN, William D. CARPENTER, Anton M. DAVYDOV, Jonathan SILVIO, Brian K. SHIRAISHI, Gregory T. SCOTT
  • Patent number: 8907187
    Abstract: A stringed musical instrument with a guitar-banjo combination sound is an apparatus that is designed to be played in the same manner as a typical guitar but is also designed to be more portable than a typical guitar. The apparatus includes a sound box coupled to a guitar neck, which allows a plurality of strings to tensioned and connected along the apparatus. The sound box is configured to produce the guitar-banjo combination sound. The sound box includes a stretched membrane, a pot chamber, a channel, and a sound chamber. The stretched membrane is perimetrically connected around the pot chamber and is used to create the banjo portion of the apparatus's sound. stretched membrane resonates the air within the pot chamber, whose sound waves travel through the channel in order to be modified by the sound chamber. A bridge is used to connect the plurality of strings to the stretched membrane.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: December 9, 2014
    Inventor: Christopher B Woods
  • Publication number: 20140123829
    Abstract: A stringed musical instrument with a guitar-banjo combination sound is an apparatus that is designed to be played in the same manner as a typical guitar but is also designed to be more portable than a typical guitar. The apparatus includes a sound box coupled to a guitar neck, which allows a plurality of strings to tensioned and connected along the apparatus. The sound box is configured to produce the guitar-banjo combination sound. The sound box includes a stretched membrane, a pot chamber, a channel, and a sound chamber. The stretched membrane is perimetrically connected around the pot chamber and is used to create the banjo portion of the apparatus's sound. stretched membrane resonates the air within the pot chamber, whose sound waves travel through the channel in order to be modified by the sound chamber. A bridge is used to connect the plurality of strings to the stretched membrane.
    Type: Application
    Filed: November 6, 2013
    Publication date: May 8, 2014
    Inventor: Christopher B. Woods
  • Patent number: 7772206
    Abstract: This invention relates to methods of treating or preventing an autoimmune disorder comprising the administration of clofarabine or a pharmaceutically acceptable salt, hydrate, solvate, clathrate, prodrug or metabolite thereof to a patient in need of such treatment. The invention further relates to methods of treating or preventing an autoimmune disorder comprising the administration of clofarabine or a pharmaceutically acceptable salt, hydrate, solvate, clathrate, prodrug or metabolite thereof and an additional therapeutic agent to a patient in need of such treatment.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: August 10, 2010
    Assignee: Genzyme Corporation
    Inventors: Christopher B. Wood, Stuart W. Smith
  • Publication number: 20090297478
    Abstract: This invention relates to methods of treating or preventing lupus comprising the administration of clofarabine or a pharmaceutically acceptable salt, hydrate, solvate or clathrate thereof to a patient in need of such treatment. The invention further relates to methods of treating or preventing lupus comprising the administration of clofarabine or a pharmaceutically acceptable salt, hydrate, solvate or clathrate thereof and an additional therapeutic agent to a patient in need of such treatment.
    Type: Application
    Filed: February 27, 2009
    Publication date: December 3, 2009
    Inventors: Christopher B. Wood, Stuart William Gordon Smith
  • Publication number: 20090155211
    Abstract: This invention relates to methods of treating or preventing an autoimmune disorder comprising the administration of clofarabine or a pharmaceutically acceptable salt, hydrate, solvate, clathrate, prodrug or metabolite thereof to a patient in need of such treatment. The invention further relates to methods of treating or preventing an autoimmune disorder comprising the administration of clofarabine or a pharmaceutically acceptable salt, hydrate, solvate, clathrate, prodrug or metabolite thereof and an additional therapeutic agent to a patient in need of such treatment.
    Type: Application
    Filed: February 27, 2009
    Publication date: June 18, 2009
    Inventors: Christopher B. Wood, Stuart William Gordon Smith
  • Patent number: 5612028
    Abstract: This invention is based upon the application of amniotic cells--in particular, viable epithelial cells--to clinical procedures including the treatment of diseased or damaged tissues, e.g. in joints denuded of cartilage and vascular grafts. The invention also provides prosthetic devices which incorporate amniotic cells, and compositions for cosmetic use based upon amniotic cells or cell extracts. A further development uses amniotic cells in the form of a semi-permeable membrane, or coated onto, for example, microspheres; these structures act as filtration devices for the removal of toxic materials from, for example, blood or urine.
    Type: Grant
    Filed: October 17, 1990
    Date of Patent: March 18, 1997
    Assignee: Genethics Limited
    Inventors: Jonathan M. Sackier, Christopher B. Wood, Rajagopallan Krishnan, Gordon R. Wiggington, Douglas Mitchel H. Butler
  • Patent number: 4910224
    Abstract: The invention is concerned with the use of certain fatty acids and inhibitors of an enzyme in effecting modifications to the lipid structure of cell membranes. The invention also relates to the formulation of pharmaceutical compositions and medicaments and to such products per se; to the treatment of a variety of clinical and veterinary disorders associated with a lowering of the saturation index of cell membranes, including malignancies, viral disorders and AIDS; and to the use of the active materials of the invention in the relief of pain.The active principals in the present invention are saturated fatty acids having from 12 to 28 carbon atoms in the alkyl chain, e.g. stearic acid, or pharmaceutically acceptable derivatives thereof; and inhibitors of the enzyme .DELTA.-9 desaturase, e.g. sterculic acid and malvalic acid or pharmacologically active derivatives or analogues thereof.
    Type: Grant
    Filed: February 13, 1987
    Date of Patent: March 20, 1990
    Inventors: Nagy A. Habib, Christopher B. Wood, Kosta Apostolov, William R. Barker